Physician profile
Scott Michael Kahn
NPI 1568665610
$2,575.43
in general payments reported to CMS, 2019-2025
36 companies · $382 in 2025
The $382 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $736 · 2020: $329 · 2021: $321 · 2022: $71.46 · 2023: $349 · 2024: $386 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,117.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $539.06 | 2021-2025 | |
| Novo Nordisk INC | $296.50 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $212.86 | 2019-2025 | |
| Amgen INC. | $207.77 | 2019-2025 | Repatha, Otezla, Evenity |
| Astrazeneca Pharmaceuticals LP | $192.88 | 2019-2024 | Airsupra |
| Astellas Pharma US INC | $116.33 | 2024-2025 | Veozah |
| Allergan, INC. | $106.21 | 2019-2020 | |
| Lilly USA, LLC | $99.77 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $71.59 | 2019-2021 | |
| Glaxosmithkline, LLC. | $65.52 | 2019-2020 | |
| Medtronic, INC. | $55.37 | 2024-2025 | Inceptiv, Intellis Adaptivestim |
| Takeda Pharmaceuticals U.S.A., INC. | $54.58 | 2019-2021 | |
| Amarin Pharma, INC. | $45.62 | 2019-2021 | |
| Corium, LLC | $41.99 | 2023 | Azstarys |
| Janssen Pharmaceuticals, INC | $36.91 | 2019-2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.03 | 2020-2021 | |
| Medtronic USA, INC. | $31.61 | 2019 | |
| Irhythm Technologies, INC. | $31.07 | 2024 | Zio Xt Patch, Zio Monitor |
| Eisai INC. | $27.98 | 2020 | |
| Sonex Health, INC. | $27.85 | 2022-2024 | Sx-One Microknife |
| Dexcom, INC. | $27.46 | 2024-2025 | Dexcom G6 Transmitter |
| Verona Pharma, INC. | $23.77 | 2025 | Ohtuvayre |
| Inspire Medical Systems, INC. | $22.83 | 2025 | Inspire |
| Biohaven Pharmaceuticals, INC. | $18.56 | 2021 | |
| Organon LLC | $17.66 | 2025 | Nexplanon |
| Ultragenyx Pharmaceutical INC. | $17.55 | 2019 | |
| Ironshore Pharmaceuticals INC. | $16.85 | 2021 | |
| Cranial Technologies, INC | $16.46 | 2019 | |
| Cardiovascular Systems INC. | $16.34 | 2020 | |
| Xeris Pharmaceuticals, INC. | $15.80 | 2021 | |
| Exact Sciences Corporation | $15.77 | 2024 | Cologuard Collection Kit |
| Nalpropion Pharmaceuticals LLC | $15.68 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $14.54 | 2020 | |
| Phadia US INC. | $14.44 | 2021 | |
| Paratek Pharmaceuticals, INC. | $14.29 | 2025 | Nuzyra, Xhance |
| Currax Pharmaceuticals LLC | $12.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Kahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.